Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 84 Colorectal Neoplasms 42 Rectal Neoplasms 40 Carcinoma, Non-Small-Cell Lung 27 Esophageal Neoplasms 24 Esophageal Squamous Cell Carcinoma 23 Stomach Neoplasms 19 Lung Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 17 Colonic Neoplasms 17 Sarcoma 15 Pancreatic Neoplasms 15 Adenocarcinoma Of Esophagus 15 Prostatic Neoplasms 13 Neoplasm Metastasis 13 Neoplasms 12 Head and Neck Neoplasms 12 Ovarian Neoplasms 11 Carcinoma, Hepatocellular 11 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Urinary Bladder Neoplasms 8 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Multiple Myeloma 6 Glioblastoma 6 Carcinoma, Renal Cell 6

Interventions

Radiotherapy, Adjuvant 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × High-Risk Cancer × Neoadjuvant Therapy × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡